Metabolic & Cardiometabolic
Part of Biotech - Drug Development
 LLY | Eli Lilly & Co. | $1.0t | $1185.18 | -0.2% | 13.6K |
 AZN | AstraZeneca PLC | $263.1b | $165.12 | -0.6% | 13.6K |
 MDGL | Madrigal Pharmaceuticals, Inc. Common Stock | $11.1b | $539.50 | 0.0% | 23 |
 PTGX | Protagonist Therapeutics, Inc | $8.5b | $152.28 | 0.0% | 1.6K |
 TERN | Terns Pharmaceuticals, Inc. Common Stock | $6.1b | $52.97 | +0.0% | 2.3M |
 KNSA | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | $5.8b | $79.00 | 0.0% | 3.6K |
 TVTX | Travere Therapeutics, Inc. Common Stock | $5.1b | $67.33 | 0.0% | 1.0K |
 VKTX | Viking Therapeutics, Inc | $3.8b | $34.48 | 0.0% | 1.8K |
 NAMS | NewAmsterdam Pharma Company N.V. Ordinary Shares | $3.2b | $28.33 | 0.0% | 41 |
 MBX | MBX Biosciences, Inc. Common Stock | $3.1b | $65.87 | 0.0% | 447 |
 MLYS | Mineralys Therapeutics, Inc. Common Stock | $2.3b | $26.48 | 0.0% | 1.4K |
 SEPN | Septerna, Inc. Common Stock | $1.6b | $41.38 | 0.0% | 2.3K |
 MAZE | Maze Therapeutics, Inc. Common Stock | $1.5b | $29.61 | 0.0% | N/A |
 MNKD | Mannkind Corporation | $1.2b | $4.10 | 0.0% | 774 |
 LXRX | Lexicon Pharmaceuticals, Inc. | $1.0b | $2.31 | 0.0% | 1.9K |
 ESPR | Esperion Therapeutics, Inc. | $0.8b | $3.19 | 0.0% | N/A |
 GYRE | Gyre Therapeutics, Inc. Common Stock | $0.6b | $6.65 | 0.0% | 82 |
 ALT | Altimmune, Inc. Common Stock | $0.6b | $3.17 | 0.0% | 18.5K |
 TENX | Tenax Therapeutics, Inc. | $0.5b | $2.13 | 0.0% | 78.9K |
 RZLT | Rezolute, Inc. Common Stock (NV) | $472.8m | $5.10 | 0.0% | 1.6K |
 SGMT | Sagimet Biosciences Inc. Series A Common Stock | $441.5m | $10.99 | 0.0% | 11.7K |
 BIOA | BioAge Labs, Inc. Common Stock | $401.9m | $9.80 | 0.0% | 622 |
 ORMP | Oramed Pharmaceuticals Inc. | $179.7m | $5.49 | 0.0% | 2.8K |
 CRDL | Cardiol Therapeutics Inc. Class A Common Shares | $146.4m | $2.10 | 0.0% | 12.4K |
 AARD | Aardvark Therapeutics, Inc. Common Stock | $144.4m | $6.50 | 0.0% | 920 |
 MIST | Milestone Pharmaceuticals Inc. Common Shares | $139.4m | $1.18 | 0.0% | 8.9K |
 VTVT | vTv Therapeutics Inc. Class A Common Stock | $127.6m | $34.23 | 0.0% | N/A |
 VANI | Vivani Medical, Inc. Common Stock (DE) | $114.7m | $1.41 | 0.0% | 216 |
 GUTS | Fractyl Health, Inc. Common Stock | $108.7m | $0.74 | 0.0% | 2.9K |
 BMEA | Biomea Fusion, Inc. Common Stock | $84.6m | $1.72 | 0.0% | 10.1K |
 VERU | Veru Inc. | $36.3m | $2.82 | 0.0% | 702 |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $26.2m | $7.09 | 0.0% | 447 |
 SKYE | Skye Bioscience, Inc. Common Stock | $20.5m | $2.01 | 0.0% | 1.7K |
 GRDX | GridAI Technologies Corp. Common Stock | $20.4m | $4.11 | 0.0% | 202 |
 NCEL | NewcelX Ltd. Ordinary Shares | $18.4m | $3.58 | 0.0% | 4.1K |
 LPCN | Lipocine Inc. | $17.5m | $2.17 | 0.0% | 500 |
 MTVA | MetaVia Inc. Common Stock | $7.6m | $1.65 | 0.0% | 1.8K |
 CVKD | Cadrenal Therapeutics, Inc. Common Stock | $6.2m | $1.55 | 0.0% | N/A |
 CURX | Curanex Pharmaceuticals Inc Common Stock | $5.8m | $4.61 | 0.0% | 11 |
 GLMD | Galmed Pharmaceuticals Ltd. | $5.1m | $4.25 | 0.0% | 15 |
 TCRT | Alaunos Therapeutics, Inc. Common Stock | $4.7m | $1.74 | 0.0% | 1.6K |
 ELAB | PMGC Holdings Inc. Common Stock | $4.2m | $5.85 | 0.0% | 716 |